Archives

November 2008
Chemical Companies Ride Out Credit Crunch
Most U.S.-based chemical companies have balance sheets that will help them weather the credit crisis, according to industry analysts. Even those firms that fund operations with commercial paper have cash balances or large revolving lines of credit. But a global recession, combined with increasingly limited availability of capital and the rising cost of debt, could be a problem. European companies are well-positioned to survive the financial turmoil; these businesses are facing higher raw material costs and shrinking margins. But many have reserves of cash and revolving credit lines to provide funds for the near term. Even though most companies met or surpassed earnings espectations for the third quarter, those earnings did decline, and many are significantly reducing their expected earnings for the end of 2008 and into 2009.

 

Eastman Wins Round in Patent Case

Wellman's motion for a preliminary injunction to stop Eastman from producing certain ParaStar Polyethylene terephthalate (PET) resins was denied by a U.S. court. Wellman filed a lawsuit against Eastman in September 2007, claiming patent infringement with regard to the ParaStar products. The motion for a preliminary injunction was filed in early 2008.

 



 
Novozymes Targets 2010 for New Biofuel Technology Launch

Novozymes announced that it plans to launch in 2010 its second-generation biofuel technology based on enzyme degradation of biomass. The new technology will reduce Carbon dioxide emissions by about 90 percent, compared to bioethenol, which reduces emissions by 30 to 70 percent. Separately, Novozymes is working with Cargill to develop a commercial process for production of bio-based Acrylic acid.

 



 
PotashCorp Reports Record Earnings, Despite Strike

Despite the ongoing strike at three of its major plants, PotashCorp reported that its third quarter earnings increased 500 percent to reach a record level of $1.24 billion. Operating income and gross margins increased nearly four-fold. According to the company, higher prices for Potash, Nitrogen and phosphate products led to the dramatic rise in sales. PotashCorp attributed a portion of upward pressure on prices to the strike.

The United Steelworkers Union (USW) has vowed to spread the strike to the company's other facilities as soon as workers at different locations are legally able to strike. The company says that the union has "paralyzed" the negotiating process and is trying to "poison the relationship between the company and its employees." The USW has filed a complaint with the Saskatchewan Labor Relations Board, claiming that a letter from PotashCorp to employees was designed to intimidate striking workers into accepting the company's offer. PotashCorp has denied any wrongdoing.
 

 



 

 
Shipping Industry Affected by Weaker Global Demand for Chemicals
The financial crisis and growing fears of a global recession have reduced activity on the spot chemicals market and thereby affected the shipping industry. With both buyers and sellers hesitating to make deals due to the high level of pricing uncertainty, there is little material to ship. In addition, many producers are cutting operating rates in response to lower demand, and that has reduced the level of spot business for shippers. Most activity is tied to contract-based orders. Those who need space are finding it much easier to come by and at a much better price than just a few months ago. In addition, players in the industry are predicting that some orders for new vessels will be cancelled due to the financial crisis.

In the U.S., shippers are also planning for stricter regulations, particularly U.S. Coast Guard inspection requirements. The frequency of drydock inspections and the types of vessels to be inspected are expected to be increased.
 

 



 

 
Ferro Sells Fine Chemicals Business
Ferro agreed to sell its fine chemicals business to Arsenal Capital Partners for $66 million. The deal is expected to close in the fourth quarter of 2008. The business, which manufactures electrolytes for energy storage devices, solvents, electronic materials and polymer, pharmaceutical and agrochemical ingredients, will be renamed Novolyte Technologies. Arsenal plans to build an energy technology company based on the business. General Manager Edward Frindt will become CEO when the deal is finalized. Ferro divested the business because it does not fit with the company's core performance materials operations.

 



 
Hexion-Huntsman Merger to Become Reality?

Following the recent decision by the Delaware Court of Chancery denying Hexion's request for cancellation of its merger with Huntsman, Hexion's owner Apollo Management announced that it would provide $540 million (Euro 394 million) to Hexion to help close the deal with Huntsman. Hexion also announced that it was working quickly to complete the merger and that it is involved in ongoing discussions with Huntsman. Appraisal firm American Appraisal is reported by Huntsman to have determined that the merger would produce a solvent company. Lenders Credit Suisse and Deutsche Bank, however, have refused to finance the deal, saying the American Appraisal opinion is not satisfactory. Hexion is now suing the banks for breach of obligation and asking the court to compel the banks to fund the transaction. The merger has received approvals from both the United States and European authorities.

 



 
Petroferm Acquired by HIG

Private equity group HIG Capital acquired surfactant technology company Petroferm for an undisclosed amount. According to HIG, the operations of Petroferm will complement the Uniqema oleochemicals business it purchased from Croda earlier in 2008. Lambent Technologies is Petroferm's largest division.

 



 
Strong Growth Still Expected for Highly Potent Compounds
Strong demand for high-potency active pharmaceutical ingredient (HPAPI) is leading many producers to expand capacity. Cambrex, Aesica Pharmaceuticals, Carbogen Amcis and Ash Stevens all plan to increase production of HPAPIs in the near future. Cambrex, which manufactures its potent compounds in the United States, is considering adding new capacity in Europe. Aesica will expand its production in the UK in 2009. Carbogen Amcis, which is a subsidiary of Dishman Pharmaceuticals & Chemicals, is constructing one of the largest HPAPI plants in the world in India. Ash Stevens is expanding its Michigan facility by 20 percent, with work to be completed in early 2010.

 



 

 
Lilly Wins Battle for Imclone; Makes Several Other Deals

An agreement for Eli Lilly and Company to acquire ImClone Systems for $6.5 billion has been approved by the boards of both companies after ImClone rejected Bristol-Myers Squibb's (BMS) offer. BMS expects to raise $1 billion through the sale of its shares in ImClone. Lilly is pursuing the merger to gain access to the biotechnology pipeline of ImClone, which includes its potential blockbuster cancer drug, Erbitux.

Recently, Lilly has also signed a $1.6 billion 10-year research agreement with Covance Inc., and a $520 million deal with Deciphera Pharmaceuticals for the development of cancer treatments. Collaborations have also been established with Quintiles Transnational Corp. and 3i. In addition, Lilly established a 50:50 joint venture with Jubilant Organosys to develop new drugs in oncology, metabolic disease, cardiovascular health and diabetes.
 

 



 
Pharma Continues to Invest
Despite challenging economic conditions, pharma companies continue to invest in R&D and make acquisitions. Sanofi-Aventis is increasing its presence in China by expanding its Shanghai facility, establishing a biometrics centre in Beijing and partnering with the Shanghai Institutes for Biological Sciences in drug discovery efforts. GlaxoSmithKline (GSK) has implemented a new funding system for its R&D efforts. Research teams must present proposals to an investment board made up of GSK executives and outside experts, who then choose which projects to support. Novartis will continue to invest in the Novartis Institutes for BioMedical Research, but R&D expenditures will be at a slower pace than during the last few years. Separately, Novartis announced that it is eliminating 550 positions in its U.S.-based sales force.

Pfizer plans to invest in several Australian biopharma companies. Overall the company is targeting six to eight new investment agreements globally per year. Novo Nordisk announced that it will spend up to $2 billion on biotech acquisitions over the next 12 months. The company believes the current financial crisis will create opportunities in biotech that weren't previously available.
 

 



 

 
Canadian Pesticide Ban Questioned by Dow

The provincial government in Quebec banned the use of 2,4-D in 2006. According to Dow AgroSciences, the ban was implemented without any scientific basis and violated the "fair and equitable treatment" provision of the North American Free Trade Agreement (NAFTA). As a result, Dow has filed a notice of intent under NAFTA to bring a claim against Canada and is seeking $1.6 million plus legal costs. The pesticide has been approved for use in several countries, including the United States, European Union and Canada (by the federal government). Other Canadian municipalities are considering the ban of certain pesticides, even though the Canadian government has approved their use.

 



 
European Legislation Could Affect Agrochemical Availability
New legislation being drafted by the European Union (EU) could lead to the banning of many pesticides from being sold in European markets. The proposal aims to ban the key ingredients used for the production of fungicides, herbicides and insecticides that make it possible to raise crops in a cost effective manner. Yields throughout Europe could fall by more than 30 percent for some crops. Pests will likely develop resistance to the few agrochemicals still available for use. In addition, some fear that farmers will turn to illegal or alternative and untested products, which could lead to serious environmental, health and safety problems.

 



 
Large Petrochemical Investments Announced for Kazakhstan
Facilities for the production of fertilizers will be built in the Uralsk, Mangystau and Aktyubinsk regions, according to a recent announcement by the Kazakhstan government. The total investment will be about $5 billion, with $500 million spent in 2009. In a separate project, state-owned KazMunaiGaz will invest $5.2 billion in a new petrochemical complex in Atyrau. However, this project is moving forward very slowly.

 



 

 
Biofuel Investment a Target for Kenya
The Kenyan government announced that foreign investors will be bringing more than $500 million worth of funds into the country over the next two years, specifically for biofuel related projects. Five international firms have already filed applications for land-lease agreements for such projects. The raw materials for these projects will include jatropha, croton, sweet sorghum and sugar, all of which need to be planted. The government expects the projects to create numerous jobs and ultimately lower energy costs.

 



 
Center to Develop New Biotech Production Routes
Scientists at the new UC-Berkeley Center for Biopharmaceutical Operations, which is scheduled to open in mid-2009, will focus on developing improved biotech processes that will hopefully lead to lower prices and a wider availability of bio-based drugs. So far, the center has received support from Bayer Healthcare and Genentech and has attracted wide interest from the biotech industry in general.

 



 
U.S. Biotech Industry Short on Cash
The financial crisis is having a dramatic affect on the biotech industry. While the largest firms are highly profitable and in good financial condition, many smaller, publicly traded companies in the sector don't have enough cash on hand to operate for even six months. Nearly 40 percent of small firms won't last a full year. At the same time, venture capital investment is declining significantly. As a way to generate needed funds, biotech start-ups are reducing employee numbers and R&D efforts. They are also hoping that big pharma will come to their aid by with licensing agreements or possibly outright purchase of the business.

 



 

 
Asian Commodity Prices Continue to Fall as Fears of Recession Rise
Even though Asian governments have taken several actions to address the growing global credit crisis, commodity chemical producers remain concerned about the possibility of a recession. Dropping crude prices are a key factor. In addition, unstable markets are leading to reduced buying, which is placing additional downward pressure on prices. Spot prices for Propylene fell to a seven-year low, while Benzene prices declined over 50 percent in the month of October to reach levels that haven't been seen since early 2006. Toluene prices are down 11 percent or more, and Acrylonitrile-butadiene-styrene (ABS) resin prices dropped to a 17-month low. Propylene oxide (PO) values have declined by more than 20 percent. Some end-users and traders have cancelled deals due to the extremely low spot prices. Many traders are being forced to renegotiate deals through outright re-pricing or with the use of discounts. Others are only accepting purchases from buyers that can pay in cash.

 



 
European Aromatics Prices Tumble
Falling crude prices and declining demand are driving European prices for aromatics ever lower. Toluene values dropped to levels not experienced since the end of 2003 before climbing slightly. Producers who rely on contract Ethylene feedstock are expecting to achieve negative margins. Meanwhile, European Benzene spot prices have plummeted nearly 70 percent in the last month to the lowest levels seen in over five years. With a global recession looming, traders expect aromatic prices to continue to track with crude values, which are likely to decline further.

 



 
Indian Majors Consider Big Investment
Indian Oil Corp. (IOC) and Gail (India) Ltd. announced their intentions to explore opportunities for establishing a $2 billion petrochemical complex in Barauni Bihar State. The memorandum of understanding signed by the companies indicates that a feasibility study will be available early next year. The companies are also considering investment by third parties. The complex would include a cracker and plants for production of Ethylene and downstream polymer products. Basic feedstock for the cracker would come from IOC's refinery in Barauni or possibly from a cross-country pipeline proposed by Gail.

 



 
New Big Petrochemical Complex Planned for Russia
The Russian government has approved a $5 billion (Euro 3.7 billion) petrochemical complex in Nizhnekamsk that is planned by OAO Taneko, a subsidiary of Tatneft. The facility will include a refinery and plants for production of Ethylene, Polyethylene and other key chemicals. It is expected to be operational in 2011.

 



 
Venezuela Plans Petrochemical Complex with Aid of non-U.S. Investors
Pequiven, Venezuela's state-run petrochemical firm, will partner with companies from around the world, including Iran's National Petrochemical, China's Sinopec and India's Reliance Industries, to build a complex consisting of seven plants producing Ethylene, Propylene, Polypropylene, Toluene, Benzene and Paraxylene. President Hugo Chavez is seeking to reduce the country's reliance on the United States as a customer. The complex is scheduled to be operative in 2014.

 



 

 
Poor Caprolactone Demand in Europe Leads to Lower Rates
Weak demand for Caprolactone combined with high stock levels and falling raw material prices have caused most European producers to reduce operating rates. Some have even cut back production by more than 25 percent.

 



 

 
Polymer Markets Face Tumultuous Times
The financial crisis and falling crude prices have created confusion in global polymer markets, making it difficult for buyers and sellers to agree on appropriate prices for products such as Polyethylene (PE), Polypropylene (PP), Polystyrene (PS) and Polyvinylchloride (PVC). Some traders are lowering prices in the hope of reducing their stocks, while many buyers seem to be overly sensitive to daily activity in the financial markets, and are holding off in making any purchases. Others are finding it difficult to get credit. And still others, particularly producers in Europe, are facing additional competition from new capacity that has come on-stream in the Middle East. North American producers will no longer be able to rely on exports to compensate for lost domestic sales. The global economic slowdown is expected to reduce downstream demand further around the world. Processors are reducing operating rates in response to the poor conditions.

 



 

 
EU Still Hopeful New Climate Control Program Will Go Forward
The environment committee of the European Parliament voted to adopt tougher rules for Europe's emission trading scheme (ETS) beginning in 2012. The legislation aims to reduce greenhouse gas emissions (GHG) by 20 percent by 2020 for most industries, plus replace free GHG emission permits with permits that must be purchased at auction. Ammonia and petrochemical plants would be included under the new rules. Before it comes into effect, though, the proposal must be voted on by the full parliament and be approved by more than two-thirds of European Union member states in the European Council of Ministers.

Despite strong opposition from some member states (Italy, Poland and other Eastern EU countries), leaders remain hopeful that the plan will be adopted by the end of the year. The opposition is based on fears that businesses in these countries cannot absorb the additional costs that will result from passage of the initiative.

European chemical trade group Cefic is also concerned about the competitiveness of the chemical industry, and is looking for some sort of benchmarking system to be implemented for distributing emission allocation rights. German trade group VCI indicated that the new ETS would significantly hurt the chemical industry in Germany and all of Europe. Production will simply move to other parts of the world, VCI representatives argued, leaving global climate change issues unaddressed as Germany loses its competitiveness. Representatives from the SME Union added that the new rules would force small- and medium-sized enterprises (SMEs) to leave Europe.
 

 



 
Green Really is Good for Business
The adoption of green chemistry initiatives may initially have been driven by consumer demands and regulatory compliance needs, but those companies that took the mission to heart are finding the decision quite profitable, too. Reducing or eliminating the use and/or generation of hazardous materials can lead to development of lower cost, more efficient processes, reduce the amount of waste produced and lower waste handling costs, reduce emissions and therefore increase compliance and potentially reduce regulatory management costs, and much more. Turning to green chemistry also helps drive innovation, leading to products that are highly differentiated from those already on the market. As a result, companies with green products often can charge a premium. Most activity is taking place in the U.S., Europe and Japan. And one sector that is hoping for great benefits is the pharma industry, which relies to a great extent on inefficient, solvent-based processes.

 



 
More Environmental Regulation and Enforcement for U.S. Chems
Chemical Companies in the United States can expect the new Congress to take stronger action on environmental issues in 2009. Democrats have already announced plans to increase oversight of the EPA, introduce tougher legislation, enforce more strictly its rules against violators and increase the use and size of penalties. A recent report by the Government Accountability Office (GAO) found that total penalties assessed by the EPA have declined by about 43 percent since 1998. Democrats hope to control the Congress in 2009, and they plan to push through an agenda for environmental reform. They have already tried unsuccessfully to introduce Reach-like legislation in 2008, and they can be expected to pursue this issue again next year.

 



 

 
Cytec CEO Retires

Current Cytec Industries CEO David Lilley will retire on Dec. 31, 2008. He will be succeeded by Shane Fleming, who is presently serving as the president and COO of the company.

 



 

 
Famous Quotes of the Month

"The man who does not work for the love of work but only for money is not likely to make money, nor find much fun in life." (Charles M. Schwab)

"Discovery consists in seeing what everyone else has seen, but understanding it for the first time." (Albert Szent-Gyorgyi)

"A happy person is not a person in a certain set of circumstances, but rather, a person with a certain set of attitudes." (Hugh Downs)
 

 



 

 
Which country gets most of its electricity from nuclear power?
According to the International Atomic Energy Agency, as of 2007 France is the leader with 78 percent. The United States gets about 19 percent of its electricity from nuclear facilities. Nuclear power reactors produce electric power in more than 30 countries, and there are more than 435 reactors worldwide. These reactors generate about 15 percent of the world's electric power. As of 2007, there were 20 more plants in construction.

 



 

 
In This Issue

 
Featured Article
 
Companies
 
Business/Finance
 
Fine & Specialty Chemicals
 
Pharma
 
Agrochemicals
 
Biotech
 
Commodity Chemicals
 
Intermediates
 
Plastics
 
General
 
Personnel
 
Famous Quotes
 
Imponderables
 

 






 

 

Corporate HQ:
9101 LBJ Frwy., Suite 310
Dallas, TX 75243 USA
Tel: (214) 349-6200
Fax: (214) 349-6286

Unsubscribe or update your email address.
Email Marketing
9101 LBJ Frwy., Suite 310 | Dallas, TX 75243